Home › Islet Cell Adenoma › Illinois
Islet Cell Adenoma clinical trials in Illinois
5 studies for Islet Cell Adenoma are looking for participants at sites in Illinois.
Cities in Illinois
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Chicago
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130), Chicago
- Northwestern Medicine Cancer Center - Warrenville ( Site 0134), Warrenville
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT04924075Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Memorial Hospital East, Shiloh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT05687123Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jan 9, 2026 · NCT06663072Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Saint Mary's Hospital, Centralia
- and 21 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT05040360From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.